Pfizer rejects link between Viagra, blindness

Following last month's report by the FDA that 38 Viagra users had gone blind as the result of non-arteritic anterior ischemic optic neuropathy, Pfizer reported that a review of all post-market optic events demonstrated that Viagra users were at no increased risk of going blind. While the agency has found no causal link between blindness and Viagra, Pfizer has agreed to report the cases on its label in order to keep physicians and patients informed.

- read this report from the AP for more

PLUS: Bayer, meanwhile, says it has not decided if it will add the information to its label for the impotence drug Levitra. One of the total of 43 cases of blindness examined by the FDA involved a man taking Levitra. Story

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.